| Stellar Resources Limited (SRZ) ORDINARY FULLY PAID |
Materials |
$37 |
Notification regarding unquoted securities - SRZ
|
23 Aug 2024 9:07AM |
$0.018 |
$0.018 |
fallen by
0%
|
|
| Graincorp Limited (GNC) ORDINARY FULLY PAID CLASS A |
Consumer Staple |
$1,466 |
Update - Notification of buy-back - GNC
|
23 Aug 2024 9:07AM |
$8.620 |
$6.610 |
fallen by
23.32%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Full Year Results Investor Presentation
|
23 Aug 2024 9:06AM |
$0.145 |
$1.560 |
risen by
975.86%
|
|
BOL - Price-sensitive ASX Announcement
Full Release
Key Points
- Boom Logistics Limited (ASX: BOL) reported a 26% increase in revenue for FY24, reaching $259 million.
- The company achieved a net profit after tax (NPAT) of $6.6 million, a significant improvement from the previous year's loss.
- Major revenue growth was seen across all key segments including resources, renewables, infrastructure, and industrials.
- Boom focused on strategic initiatives such as driving pricing increases, improving labor efficiency, and exiting low-margin contracts.
- The gearing ratio remained in line with the company's target at 41.4%, with net assets increasing by 5.5% to $111 million.
- New debt and lease financing facilities of $145 million were secured from Tier 1 banks.
- Boom Logistics invested $29.4 million in capex, with a focus on asset regeneration and growth in key markets.
- FY25 priorities include further strategic execution to improve returns, with a guidance of $8 million in NPAT.
- The company plans to focus on profitable growth in renewables and transmission lines, continuing to invest in new and replacement assets.
- Safety performance was a key metric, with one lost time injury and a total recordable injury frequency rate (TRIFR) of 3.8 per million hours worked.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Frontier Digital Ventures Limited (FDV) ORDINARY FULLY PAID |
Communication Services |
$121 |
Half year results release and conference call details
|
23 Aug 2024 9:05AM |
$0.360 |
$0.280 |
fallen by
22.22%
|
|
| Pacific Current Group Limited (PAC) ORDINARY FULLY PAID |
Financials |
$339 |
Appendix 4E and FY24 Financial Report
|
23 Aug 2024 9:05AM |
$10.700 |
$11.250 |
risen by
5.14%
|
|
PAC - Price-sensitive ASX Announcement
Full Release
Key Points
- Appendix 4E and financial report for the year ended 30 June 2024
- Revenue from ordinary activities was $42,909,000, a decrease of 5.89% from the previous year
- Net profit before tax was $142,275,000, an increase of 910.91% from the previous year
- Completion of strategic initiative to externalize investment management and sell three boutique investments
- Unfranked final dividend of 23.00 cents per share declared
- Significant increase in net assets attributed to proceeds from the sale of investments
- Details of related party transactions and key management personnel compensation provided
- Capital and operational growth highlighted through various investment and divestment activities
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| WAM Microcap Limited (WMI) ORDINARY FULLY PAID |
Financials |
$392 |
Appendix 4E and Annual Report
|
23 Aug 2024 9:04AM |
$1.445 |
$1.410 |
fallen by
2.42%
|
|
WMI - Price-sensitive ASX Announcement
Full Release
Key Points
- Investment portfolio increased by 21.6% in FY2024
- Outperformed the S&P/ASX Small Ordinaries Accumulation Index by 12.3%
- Operating profit before tax increased by 32.7% to $46.9 million
- Profit after tax increased by 30.0% to $34.2 million
- Declared fully franked final dividend of 5.25 cents per share
- Total fully franked dividend for the year is 10.5 cents per share
- Dividend yield of 7.5% and grossed-up yield of 10.7%
- Successful Share Purchase Plan and Placement raising $90 million
- Focus on investing in undervalued growth companies in the Australian micro-cap market
- Consistent investment strategy delivering 15.9% per annum return since inception in June 2017
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Block Inc. (SQ2) CDI 1:1 FOREIGN EXEMPT NYSE |
Financials |
- |
Notice of Proposed Sale of Securities
|
23 Aug 2024 9:04AM |
$96.890 |
$140.940 |
risen by
45.46%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Full Year Results Media Release
|
23 Aug 2024 9:03AM |
$0.145 |
$1.560 |
risen by
975.86%
|
|
BOL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue increased by 26% to $259.2 million.
- Net Profit After Tax (NPAT) of $6.6 million, a significant turnaround from a $5.2 million loss in FY23.
- EBITDA up 17% to $45.9 million.
- Net assets increased by 5% to $111 million.
- Cash from operating activities increased by 17% to $36.3 million.
- Operational highlights include a Lost Time Injury (LTI) rate of 1 and Total Recordable Injury Frequency Rate (TRIFR) of 3.8.
- Over $186 million in new and re-signed contracts in FY24.
- Strategic focus on improving returns, creating a sustainable future, and strengthening the balance sheet.
- Asset utilization reached 86%, with net capital expenditure of $33.3 million.
- The company plans to continue share buybacks and expects a 21% increase in NPAT for FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$17,305 |
Appendix 3Y - Christine McLoughlin
|
23 Aug 2024 9:03AM |
$304.000 |
$264.620 |
fallen by
12.95%
|
|
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$3 |
Results of Non-Renounceable Rights Issue
|
23 Aug 2024 9:02AM |
$0.008 |
$0.004 |
fallen by
50%
|
|
CUL - Price-sensitive ASX Announcement
Full Release
Key Points
- Cullen Resources Limited announced results of Non-Renounceable Rights Issue.
- Total amount raised was $739,372.
- Rights issue closed on 16 August 2024.
- Received applications for 53,418,245 Shortfall Shares.
- A total of 123,228,615 New Shares will be issued.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Annual Report to Shareholders
|
23 Aug 2024 9:02AM |
$0.145 |
$1.560 |
risen by
975.86%
|
|
| Cochlear Limited (COH) ORDINARY FULLY PAID |
Health Care |
$17,305 |
Appendix 3Y - Karen Penrose
|
23 Aug 2024 9:02AM |
$304.000 |
$264.620 |
fallen by
12.95%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Appendix 4G and Corporate Governance Statement
|
23 Aug 2024 9:02AM |
$0.145 |
$1.560 |
risen by
975.86%
|
|
| Proteomics International Laboratories Ltd (PIQ) ORDINARY FULLY PAID |
Health Care |
$51 |
Groundbreaking results for type 1 diabetes and kidney health
|
23 Aug 2024 9:01AM |
$0.835 |
$0.390 |
fallen by
53.29%
|
|
PIQ - Price-sensitive ASX Announcement
Full Release
Key Points
- Breakthrough study is the first application of the PromarkerD test for predicting renal decline in type 1 diabetes
- Results show PromarkerD demonstrated high accuracy (AUC of 0.93) in predicting chronic kidney disease in patients with type 1 diabetes
- PromarkerD has been previously validated for predicting renal decline up to four years in advance in type 2 diabetes
- The application for type 1 diabetes patients presents a new target market for PromarkerD
- The study addresses a critical health issue affecting over 537 million people worldwide with diabetes, with type 1 diabetes representing 10% of all cases
- The study involved 92 individuals with type 1 diabetes from the Fremantle Diabetes Study Phase II
- The PromarkerD test showed strong predictive accuracy with an AUC of 0.93
- PromarkerD can predict CKD risk and kidney function decline years before traditional methods
- Proteomics International Laboratories Ltd is a pioneer in predictive diagnostics
- The findings were presented at the Australasian Diabetes Conference 2024 and accepted for publication in the journal of Clinical Diabetes and Endocrinology
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Asra Minerals Limited (ASR) ORDINARY FULLY PAID |
Materials |
$5 |
Significant Drilling Programs Set to Commence at Kookynie
|
23 Aug 2024 9:00AM |
$0.006 |
$0.002 |
fallen by
66.67%
|
|
| Cullen Resources Limited (CUL) ORDINARY FULLY PAID |
Materials |
$3 |
Application for quotation of securities - CUL
|
23 Aug 2024 9:00AM |
$0.008 |
$0.004 |
fallen by
50%
|
|
| Platinum Asia Investments Limited (PAI) ORDINARY FULLY PAID |
Financials |
$372 |
Corporate Governance Statement and Appendix 4G
|
23 Aug 2024 8:58AM |
$0.960 |
$1.005 |
risen by
4.69%
|
|
| KKR Credit Income Fund (KKC) ORDINARY UNITS FULLY PAID |
Financials |
$719 |
Dividend/Distribution - KKC
|
23 Aug 2024 8:58AM |
$2.290 |
$2.230 |
fallen by
2.62%
|
|
| LGI Limited (LGI) ORDINARY FULLY PAID |
Utilities |
$253 |
Appendix 4G and Corporate Governance Statement
|
23 Aug 2024 8:57AM |
$2.950 |
$2.850 |
fallen by
3.39%
|
|
| AMCIL Limited (AMH) ORDINARY FULLY PAID |
Financials |
$332 |
Update - Notification of buy-back - AMH
|
23 Aug 2024 8:56AM |
$1.145 |
$1.050 |
fallen by
8.30%
|
|
| Platinum Asia Investments Limited (PAI) ORDINARY FULLY PAID |
Financials |
$372 |
Dividend/Distribution - PAI
|
23 Aug 2024 8:56AM |
$0.960 |
$1.005 |
risen by
4.69%
|
|
| Boom Logistics Limited (BOL) ORDINARY FULLY PAID |
Industrials |
$64 |
Appendix 4E Preliminary Final Report FY24
|
23 Aug 2024 8:56AM |
$0.145 |
$1.560 |
risen by
975.86%
|
|
BOL - Price-sensitive ASX Announcement
Full Release
Key Points
- Revenue for FY24 was $259.2 million, a 26% increase from FY23.
- Net Profit After Tax (NPAT) for FY24 was $6.6 million, compared to a $5.2 million loss in FY23.
- Income tax expense was zero due to existing tax credits.
- Net assets at 30 June 2024 were $111.0 million, up from $105.5 million at 30 June 2023.
- Base Capex for FY24 was $29.4 million, Growth Capex was $16.3 million, and asset disposals were $12.4 million.
- Debt facilities totaled $145 million, with 54% drawn as of 30 June 2024.
- Gearing ratio was 41.4% at 30 June 2024, up from 37.5% in the previous year.
- Net cash from operating activities was $36.3 million for FY24.
- The company bought back a total of 9,028,796 shares worth approximately $1.2 million in FY24.
- No dividends were declared for the period.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| ImpediMed Limited (IPD) ORDINARY FULLY PAID |
Health Care |
$69 |
FY24 Results Webinar and Investor Briefing
|
23 Aug 2024 8:56AM |
$0.054 |
$0.034 |
fallen by
37.04%
|
|
| Amcor Plc (AMC) CDI 1:1 FOREIGN EXEMPT NYSE |
Materials |
$21,565 |
Form 4 - Roegner
|
23 Aug 2024 8:55AM |
$16.180 |
$14.920 |
fallen by
7.79%
|
|
| Variscan Mines Limited (VAR) ORDINARY FULLY PAID |
Materials |
$5 |
Cleansing Statement
|
23 Aug 2024 8:54AM |
$0.009 |
$0.007 |
fallen by
22.22%
|
|
Goals & planningInvesting goal hubsSaving to build wealth
Saving for happy retirement 
Call 1300 880 160
Start a chat
Schedule a call
